FOGICAP 20

• Code: DD-01
• Ingredient : 20 mg omeprazole and 1,680 mg sodium bicarbonate in unit-dose packets
• Point :
  • FOGICAP is indicated in adults for the following cases:
  • Duodenal Ulcer
  • FOGICAP is indicated for short-term treatment of active duodenal ulcer. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy.
  • Benign Gastric Ulcer
  • FOGICAP is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer.
  • Gastroesophageal Reflux Disease (GERD)
  • Treatment of Symptomatic GERD:
  • FOGICAP is indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks.
  • Erosive Esophagitis due to acid-mediated GERD
  • FOGICAP is indicated for the short-term treatment (4-8 weeks) of erosive esophagitis which has been diagnosed by endoscopy.
  • The efficacy of FOGICAP used for longer than 8 weeks in these patients has not been established. If a patient does not respond to 8 weeks of treatment, it may be helpful to give up to an additional 4 weeks of treatment. If there is recurrence of erosive esophagitis or GERD symptoms (e.g., heartburn), additional 4-8 week courses of FOGICAP may be considered. 
  • Maintenance of Healing of Erosive Esophagitis due to acid-mediated GERD
  • FOGICAP is indicated to maintain healing of erosive esophagitis due to acid-mediated GERD. Controlled studies do not extend beyond 12 months. 
  • Reduction of Risk of Upper Gastrointestinal Bleeding in Critically Ill Patients.